Sherif Beniameen Mossad

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Prophylactic and symptomatic treatment of influenza. Current and developing options
    S B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, 9500 Euclid Ave, S 32, Cleveland, OH 44195, USA
    Postgrad Med 109:97-105; quiz 24. 2001
  2. ncbi The resurgence of swine-origin influenza A (H1N1)
    Sherif Beniameen Mossad
    Department of Infectious Diseases, S32, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 76:337-43. 2009
  3. ncbi 2008-2009 Influenza update: a better vaccine match
    Sherif B Mossad
    Department of Infectious Diseases, Section of Transplant Infectious Diseases, Medicine Institute, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 75:865-70. 2008
  4. ncbi Influenza update 2007-2008: vaccine advances, pandemic preparation
    Sherif B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 74:889-94. 2007
  5. ncbi Which agents should we use to treat and prevent influenza in 2006-2007?
    Sherif B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 73:1016-8. 2006
  6. ncbi Influenza 2005-2006: vaccine supplies adequate, but bird flu looms
    Sherif B Mossad
    Department of Infectious Diseases, The Cleveland Clinic Foundation OH 44195, USA
    Cleve Clin J Med 72:1041-7. 2005
  7. ncbi Coping with the influenza vaccine shortage
    Sherif B Mossad
    Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 71:918, 920, 923, 927. 2004
  8. ncbi Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection
    S Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA
    Bone Marrow Transplant 35:375-81. 2005
  9. ncbi Current and future therapeutic approaches to the common cold
    Sherif B Mossad
    Department of Infectious Diseases Cleveland Clinic Foundation, 9500 Euclid Avenue, S 32 Cleveland, OH, 44195, USA
    Expert Rev Anti Infect Ther 1:619-26. 2003
  10. ncbi Influenza in long-term care facilities: preventable, detectable, treatable
    Sherif B Mossad
    Section of Transplant Infectious Diseases, Department of Infectious Diseases, Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 76:513-21. 2009

Detail Information

Publications20

  1. ncbi Prophylactic and symptomatic treatment of influenza. Current and developing options
    S B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, 9500 Euclid Ave, S 32, Cleveland, OH 44195, USA
    Postgrad Med 109:97-105; quiz 24. 2001
    ..In this article, Dr Mossad discusses indications for the vaccine and compares the relative advantages and disadvantages of each of the anti-influenza drugs...
  2. ncbi The resurgence of swine-origin influenza A (H1N1)
    Sherif Beniameen Mossad
    Department of Infectious Diseases, S32, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 76:337-43. 2009
    ..As the world mobilizes for a potential pandemic, this article summarizes the developments in diagnosis, treatment, and prevention...
  3. ncbi 2008-2009 Influenza update: a better vaccine match
    Sherif B Mossad
    Department of Infectious Diseases, Section of Transplant Infectious Diseases, Medicine Institute, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 75:865-70. 2008
    ..All three antigens contained in the 2008-2009 vaccine are new. Surveillance data from the Southern Hemisphere during the summer of 2008 show that this vaccine is expected to match well the circulating strains in the Northern Hemisphere...
  4. ncbi Influenza update 2007-2008: vaccine advances, pandemic preparation
    Sherif B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 74:889-94. 2007
    ..Influenza vaccination remains our best measure to prevent epidemic and pandemic influenza. We must continue to improve vaccination rates for targeted populations. Antiviral options are currently limited to the neuraminidase inhibitors...
  5. ncbi Which agents should we use to treat and prevent influenza in 2006-2007?
    Sherif B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 73:1016-8. 2006
  6. ncbi Influenza 2005-2006: vaccine supplies adequate, but bird flu looms
    Sherif B Mossad
    Department of Infectious Diseases, The Cleveland Clinic Foundation OH 44195, USA
    Cleve Clin J Med 72:1041-7. 2005
    ..However, in the event of a pandemic of avian flu-considered inevitable by most experts, although no one knows when it will happen-the United States would be woefully unprepared...
  7. ncbi Coping with the influenza vaccine shortage
    Sherif B Mossad
    Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 71:918, 920, 923, 927. 2004
    ..The most rational solution at this time is to direct the supply of scarce vaccine to patients at highest risk of influenza-related complications...
  8. ncbi Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection
    S Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA
    Bone Marrow Transplant 35:375-81. 2005
    ..Hospital readmission rates were similar in both groups. Steroid prophylaxis significantly decreases the risk of ES following AHSCT, and is associated with shortened hospitalization, without increasing risk of infection...
  9. ncbi Current and future therapeutic approaches to the common cold
    Sherif B Mossad
    Department of Infectious Diseases Cleveland Clinic Foundation, 9500 Euclid Avenue, S 32 Cleveland, OH, 44195, USA
    Expert Rev Anti Infect Ther 1:619-26. 2003
    ..Millions of patients would benefit from an easy-to-perform diagnostic test and specific therapy that works quickly, shortening the duration of illness and preventing further spread of infection...
  10. ncbi Influenza in long-term care facilities: preventable, detectable, treatable
    Sherif B Mossad
    Section of Transplant Infectious Diseases, Department of Infectious Diseases, Medicine Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 76:513-21. 2009
    ..Factors that limit the choice of antiviral agents in this patient population include limited vaccine supplies and impaired dexterity and confusion in long-term care residents...
  11. ncbi Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults
    S B Mossad
    Department of Infectious Diseases, S 32, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    QJM 96:35-43. 2003
    ..Previous studies suggest that zinc salts may be effective in treating the common cold. Since rhinovirus infections occur primarily in the nasal cavity, an attempt to arrest the infection at the portal of entry seems logical...
  12. ncbi Common infections in clinical practice: dealing with the daily uncertainties
    Sherif Mossad
    Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 71:129-30, 133-8, 141-3. 2004
    ..In this age of growing antibiotic resistance, these include if and when to start antibiotic therapy, and which agents to use...
  13. ncbi Demystifying FluMist, a new intranasal, live influenza vaccine
    Sherif B Mossad
    Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 70:801-6. 2003
    ..Intranasal administration is expected to be more acceptable than parenteral, particularly in children, but the potential for the shedding of live virus may pose a risk to anyone with a compromised immune system...
  14. ncbi How do you manage a healthy, asymptomatic, 24-year-old with a positive RPR on a premarital blood test?
    Sherif B Mossad
    Department of Infectious Disease, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 70:101-2. 2003
  15. ncbi Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant
    Sherif B Mossad
    Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, 44195, USA
    Clin Infect Dis 36:1503-4; author reply 1504. 2003
  16. ncbi Prevention and treatment of fungal infections in bone marrow transplantation
    Sherif B Mossad
    Department of Infections Diseases, S 32, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Hematol Rep 2:302-9. 2003
    ..The optimal use of antifungal agents or their combinations remains to be determined...
  17. ncbi Influenza A and Influenza B virus infections in the same season: how unlucky can a bone marrow transplant recipient be?
    Sherif B Mossad
    Scand J Infect Dis 38:155-6. 2006
  18. ncbi Avian influenza: an emerging pandemic threat
    Xian Wen Jin
    Department of General Internal Medicine, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 72:1129-34. 2005
    ..By using stockpiled antiviral drugs effectively and developing an effective vaccine, we can be in a better position than ever to mitigate the global impact of an avian influenza pandemic...
  19. ncbi Itraconazole versus fluconazole for antifungal prophylaxis
    Sherif B Mossad
    Ann Intern Med 140:580-1; author reply 581-2. 2004
  20. ncbi Cell-mediated immune response to influenza vaccination in lung transplant recipients
    Peter J Mazzone
    Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    J Heart Lung Transplant 23:1175-81. 2004
    ..Cellular immune mechanisms serve an important role in influenza clearance. The cellular immune response to influenza vaccination has not been studied in transplant populations...